文献速递功能神经外科

「睡眠期」脑深部电刺激手术:一项文献批判性综述

"Asleep" Deep Brain Stimulation Surgery: A Critical Review of the Literature.
PubMed 文献 · World Neurosurg · 2017-05-16

本综述检索PubMed,纳入9项报告帕金森病或特发性震颤患者在不进行微电极记录或术中测试刺激情况下接受「睡眠期」脑深部电刺激(DBS)的临床结局研究。帕金森病研究显示术后6–12个月运动评分和左旋多巴等效日剂量显著改善,与「清醒期」DBS对比未见差异;作者认为初始证据表明该方式安全有效,但需长期随访、更大队列和双臂研究验证。

要点

  • 纳入9项研究(证据等级3b级3项、4级6项),8项帕金森病研究共220例患者、431个电极。
  • 帕金森病208例患者术后6–12个月统一帕金森病评定量表运动检查-III评分改善40.2%–65%。
  • 两项与「清醒期」DBS对比的研究未发现术后统一帕金森病评定量表-III改善或左旋多巴等效日剂量降低存在差异。

核心结论

  • 初始证据提示,对于帕金森病和特发性震颤,「睡眠期」DBS可在不进行微电极记录或术中测试刺激的情况下安全实施,并获得良好的临床结局。

研究设计与样本

  • 文献综述:检索PubMed,纳入所有报告帕金森病或特发性震颤患者在不进行微电极记录或术中测试刺激情况下接受DBS临床结局的研究。
  • 共纳入9项研究,证据等级为3b级(n=3)或4级(n=6)。

主要发现

  • 8项帕金森病研究(220例患者)报告了431个电极的「睡眠期」置入(341个丘脑底核,90个苍白球内侧部)。
  • 208例帕金森病患者的统一帕金森病评定量表运动检查-III评分在6–12个月时显著改善(40.2%–65%)。
  • 115例帕金森病患者的左旋多巴等效日剂量在6–12个月时显著降低(14%–49.3%),其中103例患者数据用于该分析。
  • 两项与「清醒期」DBS联合微电极记录的对比队列研究未发现术后统一帕金森病评定量表-III改善或左旋多巴等效日剂量降低存在差异。
  • 一项特发性震颤研究显示,17例接受「睡眠期」丘脑腹中间核DBS的患者与40例接受「清醒期」置入联合术中测试刺激的患者在功能结局上无差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者指出需要长期随访、更大队列和双臂研究来验证这些初始结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Although performing deep brain stimulation (DBS) with the patient under general anesthesia without microelectrode recording (MER) or intraoperative test stimulation (ITS) for movement disorders ("asleep" DBS) has become increasingly popular, its feasibility is based on the untested assumption that stereotactic accuracy correlates with positive clinical outcomes. To investigate outcomes after asleep DBS without MER or neurophysiological testing, we reviewed the medical literature on the topic. METHODS: We searched PubMed to identify all studies reporting clinical outcomes for patients who underwent DBS without MER or ITS for Parkinson disease (PD) or essential tremor (ET). RESULTS: We identified 9 studies with level 3b (n = 3) or level 4 evidence (n = 6). Eight PD studies (220 patients) reported asleep placement of 431 electrodes (341 subthalamic nucleus, 90 globus pallidus interna). Unified Parkinson Disease Rating Scale motor examination-III scores for 208 patients demonstrated significant improvement (40.2%-65%) at 6-12 months. The levodopa equivalent daily dose for 115 patients was significantly reduced (14%-49.3%) at 6-12 months in 103 patients. Two studies with a comparison cohort undergoing "awake" DBS with MER found no differences in postoperative Unified Parkinson Disease Rating Scale-III improvement or levodopa equivalent daily dose reduction. One study of asleep DBS for ET found no difference in functional outcomes between 17 patients undergoing asleep ventral intermediate nucleus DBS and 40 patients undergoing awake placement with ITS. CONCLUSIONS: Initial evidence suggests that asleep DBS can be performed safely for PD and ET with good clinical outcomes. Long-term follow-up, larger cohorts, and double-armed studies are needed to validate these initial results.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Chen T, Mirzadeh Z, Ponce FA, et al. "Asleep" Deep Brain Stimulation Surgery: A Critical Review of the Literature. World Neurosurg. 2017. PMID: 28526642. doi:10.1016/j.wneu.2017.05.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。